company background image
OMY logo

Synairgen BST:OMY Stock Report

Last Price

€0.059

Market Cap

€12.1m

7D

-26.5%

1Y

n/a

Updated

27 Mar, 2024

Data

Company Financials +

Synairgen plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Synairgen
Historical stock prices
Current Share PriceUK£0.059
52 Week HighUK£0.097
52 Week LowUK£0.038
Beta-2.29
1 Month Change-26.52%
3 Month Change-26.52%
1 Year Changen/a
3 Year Change-96.78%
5 Year Change-53.31%
Change since IPO-72.92%

Recent News & Updates

Recent updates

Shareholder Returns

OMYDE BiotechsDE Market
7D-26.5%2.1%1.9%
1Yn/a37.0%7.3%

Return vs Industry: Insufficient data to determine how OMY performed against the German Biotechs industry.

Return vs Market: Insufficient data to determine how OMY performed against the German Market.

Price Volatility

Is OMY's price volatile compared to industry and market?
OMY volatility
OMY Average Weekly Movementn/a
Biotechs Industry Average Movement5.8%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: OMY's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine OMY's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200434Richard Marsdenhttps://www.synairgen.com

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease. The company was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

Synairgen plc Fundamentals Summary

How do Synairgen's earnings and revenue compare to its market cap?
OMY fundamental statistics
Market cap€12.06m
Earnings (TTM)-€11.66m
Revenue (TTM)n/a

0.0x

P/S Ratio

-1.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OMY income statement (TTM)
RevenueUK£0
Cost of RevenueUK£0
Gross ProfitUK£0
Other ExpensesUK£9.99m
Earnings-UK£9.99m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.05
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did OMY perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.